Mycobacterium tuberculosis complex drug resistance pattern and identification of species causing tuberculosis in the West and Centre regions of Cameroon

BMC Infectious Diseases

Volumn 11, Issue , 2011, Pages

  Assam Assam, Jean Paul ^a,b   Penlap, Veronique B ^b   Cho Ngwa, Fidelis ^a   Tedom, Jean Claude ^b   Ane Anyangwe, Irene ^a   Titanji, Vincent P ^a  

^a UNIVERSITY OF BUEA   (Cameroon)

^b UNIVERSITY OF YAOUNDÉ I   (Cameroon)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CAMEROON; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LUNG TUBERCULOSIS; MALE; MYCOBACTERIUM AFRICANUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; SPUTUM SMEAR; ADOLESCENT; AGE DISTRIBUTION; AIDS RELATED COMPLEX; CLASSIFICATION; DRUG EFFECT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM; SPECIES DIFFERENCE; SPUTUM;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTITUBERCULAR AGENTS; CAMEROON; DRUG RESISTANCE, BACTERIAL; HIV INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; SPECIES SPECIFICITY; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 79955121699     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-11-94     Document Type: Article

References (23)

1. WHO (World Health Organization) Global tuberculosis control: surveillance, planning, financial. WHO report 2005 2005, Geneva, Switzerland, WHO (World Health Organization).
2. WHO (World Health Organization) Global tuberculosis control: epidemiology, strategy, financing. 2009, Geneva, Switzerland, WHO (World Health Organization).
3. WHO (World Health Organization) Tuberculosis Control: The Situation in the African Region. The 55th session of the WHO original committee for Africa held in Maputo, Mozambique, August 2005, resolution AFR/RC55/R5 2005, Geneva, Switzerland, WHO (World Health Organization).
4. WHO (World Health Organization) Anti-tuberculosis drug resistance in the world. Report number 2: Prevalence and Trends. The WHO/IUATLD global project on anti-tuberculosis drug resistance surveillance. WHO/CDS/TB/2000.278 2000, Geneva, Switzerland, WHO (World Health Organization).
5. Niobe SN, Kuaban C, Sorlin P, Cunin P, Thonnon J, Sola C, Rastogi N, Vincent V, Gutierrez MC. Genetic Biodiversity of Mycobacterium tuberculosis complex strains from patients with pulmonary tuberculosis in Cameroon. Journal of Clinical Microbiology 2003, 41(6):2547-2553. 10.1128/JCM.41.6.2547-2553.2003, 156567, 12791879.
6. Kuaban C, Bercion R, Noeske J, Cunin P, Nkamsse P, Niobe SN. Antituberculosis drug resistance in the West Province of Cameroon. Int J Tuberc Lung Dis 2000, 4(4):356-360.
7. Soini H, Musser JM. Molecular diagnosis of mycobacteria. Clinical Chemistry 2001, 47:809-814.
8. Bercion R, Kuaban C. Initial resistance to anti-tuberculosis drugs in Yaounde, Cameroon. Int J Tuberc Lung Dis 1997, 1:110-114.
9. Bercion R, Kuaban C. Resistance de Mycobacterium tuberculosis complex aux principaux antibacillaires a Yaounde, Cameroun. Bull Soc Path Ex 1998, 91:199-202.
10. Kuaban C, Bercion R, Jifon G, Cunin P, Blackett KN. Acquired anti-tuberculosis drug resistance in Yaounde, Cameroon. Int J Tuberc Lung Dis 2000, 4(5):427-32.
11. Canetti G, Rist N, Grosset J. Measurement of sensitivity of the tuberculous bacillus to antibacillary drugs by the method of proportions. Rev Tuberc Pneumol 1963, 27:217-272.
12. Godfrey-Faussett P, Sonnenberg P, Shearer SC, Bruce MC, Mee C, Morris L. Tuberculosis control and molecular epidemiology in a South African gold- mining community. Lancet 2000, 356:1066-1071. 10.1016/S0140-6736(00)02730-6, 11009142.
13. Bercion R, Kuaban C. Resistance of Mycobacterium tuberculosis complex to the principal anti-bacillary drugs in Yaounde, Cameroon. Bull Soc Path Ex 1998, 91:199-202.
14. Kuaban C, Bercion R, Jifon G, Cunin P, Blackett KN. Acquired anti-tuberculosis drug resistance in Yaounde, Cameroon. Int J Tuberc Lung Dis 2000, 4(5):427-32.
15. Cohn DL, Bustreo F, Raviglione MC. Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD global surveillance project. Clin Infect Dis 1997, 24:S121-S130. 10.1093/clinids/24.Supplement_1.S121, 8994791.
16. WHO (World Health Organisation) Anti tuberculosis drug resistance in the world. The WHO/IUATLD Global project on anti-tuberculosis drug resistance surveillance 1997, Geneva: World Health Organization. Geneva, Switzerland, WHO/TB/97.229, WHO (World Health Organisation).
17. Bretzel G, Aziz M, Wendl-Richter U, Adatu F, Aisu T, van Wijnen A, Sticht-Groh V. Anti-tuberculosis drug resistance surveillance in Uganda 1996-1997. Int J Tuberc Lung Dis 1999, 3(9):810-5.
18. Jereb JA, Kelly GD, Dooley SW, Cauthen GM, Snider DE. Tuberculosis mortality in the United States final data, 1990. MMWR CDC Surveillance 1991, 40:23-28.
19. Akcaly S. In-vitro susceptibility of Mycobacterium tuberculosis strains to first-line antituberculosis drugs in Manisa region. Microbiology specialist thesis, Manisa 2000,
20. Zignol M, Hosseini MS, Wright A, Weezenbeek CL, Nunn P, Watt CJ, Williams BG, Dye C. Global incidence of multidrug-resistant tuberculosis. J Infect Dis 2006, 194:479-485. 10.1086/505877, 16845631.
21. Kochi A, Vareldris B, Styblo K. Multidrug-resistant tuberculosis and its control. Res Microbiol 1993, 144:104-110. 10.1016/0923-2508(93)90023-U, 8337467.
22. Wells CD, Cegielski JP, Nelson LJ, Laserson KF, Holtz TH, Finlay A, Castro KG, Weyer K. HIV infection and multidrug resistance -the perfect storm. J Infect Dis 2007, 196(Suppl 1):S86-S107. 10.1086/518665, 17624830.
23. Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, Zeller K, Andrews J, Friedland G. Extensively drug resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006, 368:575-1580. 10.1016/S0140-6736(06)69573-1, 16905011.